Browsing publications by Professor Farhad Kamali

Newcastle AuthorsTitleYearFull text
Salah Abohelaika
Professor Farhad Kamali
Dr Peter Avery
Dr Patrick Kesteven
Dr Hilary Wynne
et al.
Anticoagulation control and cost of monitoring of older patients on chronic warfarin therapy in three settings in North East England2014
Salah Abohelaika
Dr Tina Biss
Dr Hilary Wynne
Professor Farhad Kamali
C0170: The Impact of Dietary Vitamin K on the Pharmacological Activity of FXa Inhibitor Rivaroxaban in Man2014
Dr Tina Biss
Professor Farhad Kamali
Characterizing variability in warfarin dose requirements in children using modelling and simulation2014
Professor Farhad Kamali
Genotype-Guided Dosing of Vitamin K Antagonists [Reply]2014
Dr Tina Biss
Dr Peter Avery
Emily Swinburne
Professor Farhad Kamali
Maintenance warfarin dose in children is determined by S-warfarin clearance which is in turn influenced by CYP2C9 genotype2014
Professor Ann Daly
Professor Farhad Kamali
Patients Benefit From Genetics-Guided Coumarin Anticoagulant Therapy2014
Salah Abohelaika
Dr Tina Biss
Dr Peter Murphy
Professor Farhad Kamali
The impact of dietary vitamin K on the pharmacological activity of FXa inhibitor rivaroxaban in man2014
Dr Patrick Kesteven
Professor Ann Daly
Dr Peter Avery
Professor Farhad Kamali
A Randomized Trial Comparing Genotype-Guided Dosing of Warfarin to Standard Dosing: The EU Pharmacogenetics of Anticoagulant Therapy (EU-PACT) Warfarin Study2013
Dr Patrick Kesteven
Julian Leathart
Professor Ann Daly
Professor Farhad Kamali
A Randomized Trial of Genotype-Guided Dosing of Warfarin2013
Professor Farhad Kamali
Dr Hilary Wynne
Dr Patrick Kesteven
Dr John Hanley
Dr Jing Shen
et al.
Improving the safety and efficacy of anticoagulation therapy for thromboembolic disease through Vitamin K2013
1234567891011